SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
ENZ
--
0.00%
--
Enzo Biochem to provide COVID-19 testing at 50+ New York pharmacies
Enzo Biochem (ENZ -0.6%) partners with Community Pharmacy Enhanced Services Network, to provide COVID-19 testing at 52 of the network’s 155 pharmacies acro
seekingalpha · 07/21 18:52
ENZO BIOCHEM TO PROVIDE ACCESS TO COVID-19 TESTING AT MORE THAN 50 NY PHARMACIES IN COLLABORATION WITH CPESN NY
NEW YORK, NY, July 21, 2020 -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostic company, and Community Pharmacy Enhanced Services Network (CPESN® NY), the.
GlobeNewswire · 07/21 12:30
FDA OKs emergency use of Enzo Bio's COVID-19 test
Enzo Biochem (NYSE:ENZ) soared 21% yesterday as its Ampiprobe SARS-CoV-2 Test System was granted Emergency Use Authorization by the FDA in a letter. The le
seekingalpha · 07/09 15:58
CLNE, NTES among premarket gainers
Seeking Alpha - Article · 07/09 12:19
Enzo Biochem's COVID test granted emergency authorization from the FDA
Seeking Alpha - Article · 07/09 10:58
Enzo Biochem to Provide COVID-19 Testing to Farmingdale State College Staff and Students as They Return to Campus
GlobeNewswire · 06/30 18:15
Should You Avoid Enzo Biochem, Inc. (ENZ)?
Insider Monkey · 06/25 22:50
Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I
GlobeNewswire · 06/23 13:30
Enzo Announces Issuance Of U.S. Patent for Methods Of Treating Liver Cancer Using Proprietary Compound SK1-I
Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I Continues to Explore Opportunities for Use of the Compound as a Potential Treatment for COVID-19 NEW YORK,
Benzinga · 06/23 12:31
Edited Transcript of ENZ earnings conference call or presentation 8-Jun-20 9:00pm GMT
Thomson Reuters StreetEvents · 06/10 09:57
Enzo Biochem records weak Q3
Seeking Alpha - Article · 06/09 20:01
Enzo Biochem (ENZ) Investor Presentation - Slideshow
Seeking Alpha - Article · 06/09 17:59
Enzo Biochem, Inc. (ENZ) Q3 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 06/09 00:16
Enzo Biochem Reports Third Quarter 2020 Financial Results
GlobeNewswire · 06/08 21:05
Enzo Biochem Q3 EPS $(0.21) Down From $(0.14) YoY, Sales $17.00M Miss $20.92M Estimate
Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.21) per share. This is a 50 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $17.00
Benzinga · 06/08 20:06
The Week Ahead In Biotech: Viela FDA Decision, Hematology Conference Take Center Stage
The biotech space saw a flurry of activity last week, with coronavirus-related news, conference presentations and IPOs.
Benzinga · 06/07 17:43
Enzo Biochem to Announce Third Quarter 2020 Financial Results on Monday June 8, 2020
NEW YORK, NY, June 03, 2020 -- Enzo Biochem, Inc.  (NYSE: ENZ) a leading biosciences and diagnostics company, today announced that it will release its third quarter 2020.
GlobeNewswire · 06/03 20:05
LOW, INO among premarket gainers
Seeking Alpha - Article · 05/20 13:22
Enzo nabs new patent in U.S. for treatment of osteoporosis
Seeking Alpha - Article · 05/12 12:38
Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin
Enzo Biochem, Inc.  (ENZ) a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,626,170 entitled Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor. The patent is dire
GlobeNewswire · 05/12 12:00